Stripping solvent, blank biological liquid matrix and preparation method, application and kit thereof
By using peeling solvents of alcohol and ether and layering treatment with biological liquid, the problems of complex removal steps of activated carbon and poor removal of fat-soluble substances are solved, and the efficient preparation of blank biological liquid matrix is achieved, which is suitable for detection of calibrated products and quality control products. Preparation.
Patent Information
- Application Number
- CN202411203949.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-30
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-08-30
AI Technical Summary
During the preparation of existing blank biological liquid matrix, the activated carbon removal steps are complex and the fat-soluble substance removal effect is poor, resulting in a high base amount of vitamins, ceramides and other substances in the matrix, which does not meet the detection requirements.
Use peeling solvents of alcohol and ether, formulated according to specific mass percentages, and are used to mix with biological liquids to remove target substances in layers to form blank biological liquid matrix, including alcohol content of 1-35%, ether content of 65-99%, and through Multiple stratification and rotary evaporation were further purified.
Effectively remove fat-soluble vitamins, ceramides and other substances in biological liquids, forming a blank matrix similar to the composition of unstripped biological liquids. It is suitable for the preparation of detection calibration products and quality control products, significantly reducing the content of target substances.
Smart Images

Figure CN118707010B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of laboratory testing, and more specifically to a stripping solvent for preparing a blank biological liquid matrix, a blank biological liquid matrix, a preparation method thereof, an application thereof, and a kit. Background Art
[0002] Blank biological liquid matrix is crucial to the accuracy of clinical test results. Blank biological liquid matrix is a matrix with the target analyte content controlled within a certain range and similar composition to the clinical test sample. Blank biological liquid matrix can be used to prepare calibrators and quality control products during clinical testing, thereby correcting the loss of target substances during sample pretreatment and correcting the matrix effect during sample testing.
[0003] At present, blank biological liquid matrices are prepared by adsorption materials such as activated carbon. The preparation process has the problem that the activated carbon removal steps are complicated and the removal effect of fat-soluble substances is poor. For example, the background content of fat-soluble vitamins, ceramides, etc. in the blank biological liquid matrix after treatment is high and does not meet the detection requirements. Summary of the invention
[0004] An object of the present invention is to provide a new technical solution for the stripping solvent preparation of blank biological fluid matrices.
[0005] According to a first aspect of the present invention, a stripping solvent for preparing a blank biological liquid matrix is provided, wherein the stripping solvent comprises alcohol and ether, wherein the alcohol content is 1 to 35% and the ether content is 65 to 99% calculated by mass percentage.
[0006] Optionally, the content of the ether is 65% to 95%, and the content of the alcohol is 5% to 35%.
[0007] Optionally, the alcohol includes at least one of a monohydric alcohol and a polyhydric alcohol.
[0008] Optionally, the ether includes at least one of a monoether and a mixed ether.
[0009] Optionally, the ether includes at least one of dimethyl ether, diethyl ether, dipropyl ether, methyl ethyl ether, ethyl propyl ether, methyl propyl ether, and methyl tert-butyl ether, and the alcohol includes at least one of methanol, ethanol, propanol, isopropanol, butanol, ethylene glycol, propylene glycol, glycerol, and sorbitol;
[0010] Optionally, the ratio of the alcohol content to the ether content is 5:95 to 25:75.
[0011] Optionally, the alcohol includes isopropanol, the ether includes methyl tert-butyl ether, and the ratio of the isopropanol content to the methyl tert-butyl ether content is 25:75 to 10:90.
[0012] Optionally, the alcohol includes isopropanol and ethanol, the ether includes methyl tert-butyl ether, and the ratio of the isopropanol content, the ethanol content and the methyl tert-butyl ether content is (5-15): (1-10): (75-94).
[0013] Optionally, the alcohol includes n-butanol and ethanol, the ether includes methyl tert-butyl ether, and the ratio of the content of n-butanol, the content of ethanol and the content of methyl tert-butyl ether is (2-10): (6-15): (75-92); or
[0014] The alcohol includes isopropanol and glycerol, and the ether includes methyl tert-butyl ether. The ratio of the content of the isopropanol, the content of the glycerol and the content of the methyl tert-butyl ether is (10-20): (2-8): (72-88).
[0015] According to a second aspect of the present application, a method for preparing a blank biological liquid matrix is provided. The preparation method comprises: mixing a biological liquid with a stripping solvent for preparing a blank biological liquid matrix as described in the present application, layering to obtain a first organic phase layer and a first main phase layer, removing the first organic phase layer to obtain the first main phase layer, wherein the first main phase layer is a blank biological liquid matrix.
[0016] Optionally, the biological fluid includes at least one of whole blood, plasma, serum, saliva, urine, cerebrospinal fluid, and milk.
[0017] Optionally, the volume ratio of the stripping solvent to the biological fluid is greater than or equal to 1:2.
[0018] Optionally, the blank biological liquid matrix is dried to prepare a dry powder; or
[0019] The method also includes purifying the blank biological liquid matrix, including: adding ether to the obtained blank biological liquid matrix, mixing, layering to obtain a second organic phase layer and a second main phase layer, and removing the second organic phase layer.
[0020] Optionally, the second main phase layer is subjected to rotary evaporation to remove the ether in the second main phase layer.
[0021] Optionally, the second main phase layer is dried to prepare a dry powder; preferably, the second main phase layer is dried by freeze-drying.
[0022] According to a third aspect of the present application, a blank biological liquid matrix is provided. The blank biological liquid matrix is prepared according to the preparation method described in the present application.
[0023] According to a fourth aspect of the present application, there is provided a use of a blank biological liquid matrix in detecting fat-soluble vitamins, ceramides or steroid hormones.
[0024] According to a fifth aspect of the present application, a kit is provided, which comprises the blank biological liquid matrix described in the present application.
[0025] In the embodiment of the present application, the stripping solvent can effectively remove target substances in the biological liquid, such as fat-soluble vitamins, ceramides, steroid hormones, etc., thereby forming a blank biological liquid matrix. The blank biological liquid matrix has a similar composition to the unstripped biological liquid and can be used as a calibration substance or quality control substance for detecting target substances, such as fat-soluble vitamins, ceramides, steroid hormones, etc.
[0026] Further features and advantages of the present invention will become apparent from the following detailed description of exemplary embodiments of the present invention with reference to the attached drawings. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] The accompanying drawings, which are incorporated in and constitute a part of the specification, illustrate embodiments of the present invention and, together with the description, serve to explain the effects of the present invention.
[0028] Figure 1 This is a chromatogram of 7 types of ceramides in the mixed plasma of Example 2 of the present application.
[0029] Figure 2 This is a chromatogram of 7 ceramides in the blank plasma matrix of Example 2 of the present application.
[0030] Reference signs: 1. Cer(d18:1 / 14:0); 2. Cer(d18:1-d7 / 14:0); 3. Cer(d18:1 / 16:0); 4. Cer(d18:1-d7 / 16:0); 5. Cer(d18:1 / 18:0); 6. Cer(d18:1-d7 / 18:0); 7. Cer(d18:1 / 20:0); 8. Cer(d18:1-d7 / 20:0); 9. Cer(d18:1 / 22:0); 10. Cer(d18:1-d7 / 22:0); 11. Cer(d18:1 / 24:0); 12. Cer(d18:1-d7 / 24:0); 13. Cer(d18:1 / 24:1); 14. Cer(d18:1-d7 / 24:1). DETAILED DESCRIPTION
[0031] Various exemplary embodiments of the present invention will now be described in detail with reference to the accompanying drawings. It should be noted that the relative arrangement of components and steps, numerical expressions and numerical values set forth in these embodiments do not limit the scope of the present invention unless otherwise specifically stated.
[0032] The following description of at least one exemplary embodiment is merely illustrative in nature and is in no way intended to limit the invention, its application, or uses.
[0033] Technologies, methods, and equipment known to ordinary technicians in the relevant art may not be discussed in detail, but where appropriate, the technologies, methods, and equipment should be considered part of the specification.
[0034] In all examples shown and discussed herein, any specific values should be interpreted as merely exemplary and not limiting. Therefore, other examples of the exemplary embodiments may have different values.
[0035] It should be noted that like reference numerals and letters refer to similar items in the following figures, and therefore, once an item is defined in one figure, it need not be further discussed in subsequent figures.
[0036] According to the first embodiment of the present application, a stripping solvent for preparing a blank biological liquid matrix is provided. The stripping solvent includes alcohol and ether, and the content of the alcohol is 1% to 35% and the content of the ether is 65% to 99% calculated by mass percentage. The blank biological liquid matrix can be used to prepare calibration products, quality control products, etc.
[0037] In the embodiment of the present application, the stripping solvent can effectively strip target substances in biological fluids, such as fat-soluble vitamins, ceramides, steroid hormones, and the like, thereby forming a blank biological fluid matrix. The blank biological fluid matrix has a similar protein concentration to the unstripped biological fluid, and the retention time of the target substances in the matrix before and after stripping is similar, and can be used for the preparation of calibration products and quality control products for detecting target substances, such as fat-soluble vitamins, ceramides, steroid hormones, and the like.
[0038] Optionally, the content of alcohol is 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, etc. Correspondingly, the content of ether is 65%, 70%, 75%, 80%, 85%, 90%, 95%, 99%, etc.
[0039] The contents of fat-soluble vitamins, ceramides and steroid hormones in the blank biological liquid matrix are extremely low, and therefore the blank biological liquid matrix can be used for the preparation of calibration products and quality control products in the detection of fat-soluble vitamin concentrations, ceramide concentrations and steroid hormone concentrations in biological liquids.
[0040] By LC-MS / MS detection, the content of target substances (e.g., fat-soluble vitamins, ceramides, steroid hormones) in the blank biological liquid matrix can be obtained, and the removal rate and content of the target substances after removal in the blank biological liquid matrix can be determined.
[0041] In one example, the content of the ether is 65% to 95%, and the content of the alcohol is 5% to 35%.
[0042] If the alcohol content is too high, protein precipitation will be formed during the stripping process of the target substance (e.g., fat-soluble vitamins, ceramides, steroid hormones) in the biological fluid, resulting in a large difference in the matrix between the blank biological fluid and the biological fluid; conversely, if the alcohol content is too low, the removal rate of the target substance is low. Optionally, the alcohol content is 5%, 10%, 15%, 20%, 25%, 30%, 35%, etc. Correspondingly, the ether content is 65%, 70%, 75%, 80%, 85%, 90%, 95%, etc. Within the above range, the stripping solvent can effectively remove the target substance in the biological fluid, and no protein precipitation will be formed during the stripping process.
[0043] In one example, the alcohol includes at least one of a monohydric alcohol and a polyhydric alcohol.
[0044] Optionally, the monohydric alcohol includes methanol, ethanol, propanol, butanol or isopropanol, etc. The polyhydric alcohol includes ethylene glycol, propylene glycol, glycerol or sorbitol, etc.
[0045] Preferably, the alcohol does not include structurally unstable enols, which have poor stability and whose hydroxyl groups may become carbonyl groups during use, resulting in failure to effectively remove the target substance.
[0046] In one example, the ether includes at least one of a monoether and a mixed ether.
[0047] Optionally, the monoether includes dimethyl ether, diethyl ether (ie, diethyl ether), dipropyl ether, etc. The mixed ether includes methyl ethyl ether, ethyl propyl ether, methyl propyl ether, methyl tert-butyl ether, etc.
[0048] Preferably, the ether does not include water-miscible ethers, active cyclic ethers, and crown ethers that can complex metal ions in biological matrices. Water-miscible ethers cannot be separated after mixing with biological fluids, resulting in the inability to strip the target substance. Active cyclic ethers easily react with the target substance in the biological fluid, thereby affecting the composition of the blank biological fluid matrix. Crown ethers can complex with metal ions in the biological fluid, thereby causing a difference in ionic strength between the prepared blank biological fluid matrix and the biological fluid.
[0049] In one example, the ether includes at least one of dimethyl ether, diethyl ether, dipropyl ether, methyl ethyl ether, ethyl propyl ether, methyl propyl ether, and methyl tert-butyl ether, and the alcohol includes at least one of methanol, ethanol, propanol, isopropanol, butanol, ethylene glycol, propylene glycol, glycerol, and sorbitol.
[0050] In this example, the ether can effectively remove the target substance in the biological fluid. The ether is miscible with methanol, ethanol, propanol, isopropanol, butanol, ethylene glycol, propylene glycol, glycerol, sorbitol, etc., thereby further improving the stripping efficiency of the stripping solvent.
[0051] In one example, the ratio of the alcohol content to the ether content is 5:95 to 25:75.
[0052] In this example, the stripping solvent includes ether and alcohol mixed together. Optionally, the ratio of the content of the alcohol to the content of the ether is 5:95, 10:90, 12:88, 15:85, 18:82, 20:80, 22:78, 25:75, etc. Within the above range, the stripping solvent can effectively remove fat-soluble vitamins, ceramides, steroid hormones and other substances in the biological fluid, and no protein precipitation will be formed during the stripping process.
[0053] In one example, the alcohol includes isopropanol, the ether includes methyl tert-butyl ether, and the ratio of the content of the isopropanol to the content of the methyl tert-butyl ether is 25:75 to 10:90; in this example, the stripping solvent includes methyl tert-butyl ether and isopropanol mixed together. Optionally, the above content ratio is 10:90, 12:88, 15:85, 18:82, 20:80, 22:78, 25:75, etc. Within the above range, the stripping solvent has a good stripping effect on substances such as fat-soluble vitamins, ceramides, and steroid hormones.
[0054] In one example, the alcohol includes isopropanol and ethanol, the ether includes methyl tert-butyl ether, and the ratio of the isopropanol content, the ethanol content and the methyl tert-butyl ether content is (5-15): (1-10): (75-94).
[0055] In this example, the stripping solvent includes methyl tert-butyl ether, ethanol and isopropanol mixed together. Optionally, the above content ratio is 5:1:94, 6:4:90, 7:4:89, 8:5:87, 10:6:84, 12:8:80, 14:8:78, 15:10:75, etc. Within the above range, the stripping solvent has a good stripping effect on substances such as fat-soluble vitamins, ceramides, steroid hormones, etc.
[0056] In one example, the alcohol includes n-butanol and ethanol, the ether includes methyl tert-butyl ether, and the ratio of the content of n-butanol, the content of ethanol and the content of methyl tert-butyl ether is (2-10): (6-15): (75-92).
[0057] In this example, the stripping solvent includes n-butanol, ethanol and methyl tert-butyl ether mixed together. Optionally, the above content ratio is: 2:6:92, 4:7:89, 5:10:85, 6:12:82, 7:13:80, 9:11:80, 10:15:75, etc. Within the above range, the stripping solvent has a good stripping effect on substances such as fat-soluble vitamins, ceramides, steroid hormones, etc.
[0058] In one example, the alcohol includes isopropanol and glycerol, the ether includes methyl tert-butyl ether, and the ratio of the isopropanol content, the glycerol content and the methyl tert-butyl ether content is (10-20): (2-8): (88-72).
[0059] In this example, the stripping solvent includes isopropyl alcohol, glycerol and methyl tert-butyl ether mixed together. Optionally, the above content ratio is: 10:6:84, 12:8:80, 15:5:80, 16:5:79, 17:5:78, 18:4:78, 19:7:74, 20:8:72, etc. Within the above range, the stripping solvent has a good stripping effect on substances such as fat-soluble vitamins, ceramides, steroid hormones, etc.
[0060] According to a second embodiment of the present application, a method for preparing a blank biological liquid matrix is provided. The preparation method comprises mixing a biological liquid with a stripping solvent for preparing a blank biological liquid matrix provided in an embodiment of the present application, layering to obtain a first organic phase layer and a first main phase layer, removing the first organic phase layer to obtain the first main phase layer, wherein the first main phase layer is a blank biological liquid matrix.
[0061] In the specific implementation, first, according to the lipophilicity of the target analyte, the types and proportions of alcohol and ether are adjusted. Preferably, the content of the alcohol is 1 to 35%, and the content of the ether is 65% to 99% by mass. Within this range, the ratio of alcohol and ether is adjusted to avoid protein precipitation in the biological fluid. After the stripping solvent is prepared, it can be placed in a brown reagent bottle and stored away from light.
[0062] Then, according to a fixed value that the volume ratio of the stripping solvent to the biological liquid is greater than or equal to 1:2, the stripping solvent is added to the container containing the biological liquid, and mixed evenly, for example, centrifuged by a centrifuge to perform stratification. For example, the first main phase layer is the aqueous phase layer. Since the density of the first organic phase layer is less than the density of the aqueous phase layer, the first organic phase layer is located on the first main phase layer. The target substance is dissolved in the first organic phase layer. The first organic phase layer is removed, and the remaining first main phase layer is a blank biological liquid matrix.
[0063] After the above preparation method, the protein concentration of the blank biological fluid matrix is similar to the protein concentration of the biological fluid before stripping.
[0064] The preparation method can effectively remove target substances in biological fluids, such as fat-soluble vitamins, steroid hormones, ceramides, etc., to obtain a blank biological fluid matrix. The blank biological fluid matrix has a low content of target substances and can be used for the preparation of calibrators and quality control products in in vitro diagnostic reagents or scientific research reagents to detect the content of target substances in biological fluids.
[0065] Preferably, in order to better preserve the blank biological liquid matrix, the obtained blank biological liquid matrix is dried to prepare a dry powder. For example, the blank biological liquid matrix is prepared into a dry powder by freeze drying. This method can remove the organic solvent in the blank biological liquid matrix and preserve the blank biological liquid matrix. When in use, the dry powder can be reconstituted with ultrapure water.
[0066] Optionally, the biological fluid includes at least one of whole blood, plasma, serum, saliva, urine, cerebrospinal fluid, and milk.
[0067] In one example, the volume ratio of the stripping solvent to the biological fluid is greater than or equal to 1:2.
[0068] In the above range, the removal efficiency of the target substance in the biological fluid is high.
[0069] Optionally, the volume ratio of the stripping solvent to the biological liquid is 1:2, 1:1, 1.5:1, 2:1, 2.5:1, 3:1, etc. During preparation, setting the amount of biological liquid and stripping solvent according to the above volume ratio can effectively remove the target substance in the biological liquid.
[0070] In one example, the preparation method further includes purifying the blank biological liquid matrix, including: adding ether to the obtained blank biological liquid matrix, mixing, layering to obtain a second organic phase layer and a second main phase layer, and removing the second organic phase layer.
[0071] Since the stripping solvent contains alcohol and ether, the two substances will be partially miscible in the blank biological liquid matrix during the preparation of the blank biological liquid matrix. In this example, by adding ether to the blank biological liquid matrix and mixing it thoroughly, after stratification, the alcohol in the blank biological liquid matrix can be effectively removed. For example, stratification is performed by centrifugation to obtain a second organic phase layer and a second main phase layer, and the second organic phase layer is removed. The second main phase layer is an aqueous phase layer. Since the density of the aqueous phase layer is greater than the density of the second organic phase layer, the second organic phase layer is located above the second main phase layer. After removing the second organic phase layer, the alcohol content in the blank biological liquid matrix is greatly reduced, thereby effectively purifying the blank biological liquid matrix.
[0072] To further purify the blank biological fluid matrix, multiple additions of ether and removal of the second organic phase layer can be performed.
[0073] Preferably, the volume ratio of the ether to the first main phase layer is greater than or equal to 1:1. The types of ether are as described above. Optionally, the volume ratio of the ether to the first main phase layer is 1:1, 1.5:1, 2:1, 2.5:1, 3:1, etc. Within this range, the alcohol in the first main phase layer can be effectively removed.
[0074] In one example, the preparation method further comprises rotary evaporating the second main phase layer to remove the ether in the second main phase layer.
[0075] Rotary evaporation is a method of rapidly evaporating the solvent of a sample by rotating and heating the sample container under reduced pressure, thereby concentrating or separating the solutes in the sample. This method can effectively remove the ether in the second main phase layer.
[0076] The method for removing the ether in the second main phase layer may also be to dry the second main phase layer to prepare a dry powder; preferably, the second main phase layer is dried by freeze-drying.
[0077] During the drying process, ether gradually evaporates. By drying the blank biological liquid matrix and preparing it into a dry powder, the ether and other organic solvents in the blank biological liquid matrix can be effectively removed. In addition, the dry powder is conducive to the preservation of the blank biological liquid matrix. When used, the dry powder can be re-dissolved with a solvent, such as ultrapure water. The volume of the added solvent can be determined according to the ratio of volatile matter to dry powder after the corresponding biological liquid is dried without stripping treatment and the mass of the dry powder.
[0078] According to a third embodiment of the present application, a blank biological liquid matrix is provided, which is prepared according to the preparation method described in the present application.
[0079] The target substance in the blank biological liquid matrix has a low content and can be used to configure quality control products and calibration products for target substance detection, so that the accuracy of the target substance in the biological liquid is high.
[0080] According to a fourth embodiment of the present application, there is provided a use of a blank biological liquid matrix in detecting fat-soluble vitamins, ceramides or steroid hormones.
[0081] The blank biological fluid matrix has a similar protein concentration to that of the unstripped biological fluid and can be used to detect target substances in the biological fluid, such as fat-soluble vitamins, ceramides, steroid hormones, etc. For example, it can be used for the preparation of calibrators and quality control products.
[0082] According to a fifth embodiment of the present application, a kit is provided, which includes the blank biological liquid matrix provided in the present application.
[0083] For example, the blank biological liquid matrix can be prepared as a dry powder. When used, ultrapure water is used to dissolve the dry powder to obtain a reconstituted blank biological liquid matrix. Since the kit uses the blank biological liquid matrix of the embodiment of the present application to prepare calibration products and quality control products, the detection of the target substance is more accurate.
[0084] <Example 1>
[0085] Preparation of blank serum matrix for fat-soluble vitamins
[0086] The biological fluid is human serum. Human sera from multiple sources are mixed together, for example, sera from 30 people are mixed together, i.e., mixed serum. Part of the mixed human serum is used to prepare a blank biological fluid matrix, and part is used for comparison.
[0087] In the stripping solvent, the mass percentages of isopropanol, ethanol and methyl tert-butyl ether are 10%, 5% and 85% respectively, and all three reagents are chromatographically pure reagents. The stripping solvent is mixed evenly by vortex mixing. The stripping solvent is added to human serum at a volume ratio of 1:1.5 between the first main phase layer and the stripping solvent, mixed at 1000 rpm for 40 minutes, and the mixed solution is centrifuged at 4000 rpm for 10 minutes to obtain a layered liquid, with the first organic phase layer on the upper layer and the first main phase layer on the lower layer. The first organic phase layer is removed. The first main phase layer is mixed with methyl tert-butyl ether at a volume ratio of 1:1.5 between the first main phase layer and methyl tert-butyl ether, and mixed at 1000 rpm for 40 minutes. Centrifuge at 4000 rpm for 10 minutes to obtain a layered liquid. The second organic phase layer is on the upper layer. The second main phase layer is on the lower layer. The second organic phase layer is removed to obtain a blank serum matrix. Finally, the blank serum matrix is freeze-dried to obtain a dry powder of the blank serum matrix.
[0088] test:
[0089] The dry powder of the blank serum matrix is reconstituted with ultrapure water to obtain a blank serum matrix in a solution state. In this embodiment, the ratio of ultrapure water to dry powder is 10.9472, that is, when the mass of the dry powder of the blank serum matrix is 1g, 10.9472g of ultrapure water is added for reconstitution.
[0090] The results were analyzed by liquid chromatography-tandem mass spectrometry (SCIEX Triple Quad TM 4500 MD LC-MS / MS system) was used to detect the contents of the five fat-soluble vitamins in the blank serum matrix of this example and the unstripped human serum of this example, and the removal rates were calculated. The detection results are shown in Table 1.
[0091] Table 1 - Comparison of the contents of five fat-soluble vitamins in blank serum matrix and unstripped human serum in Example 1
[0092]
[0093] Note: If the target substance peak signal-to-noise ratio in the test results is less than 3, the content is marked as 0.
[0094] As shown in Table 1, the contents of fat-soluble vitamin A1, 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, vitamin E and vitamin K1 in the blank serum matrix were all reduced by more than 99% compared with the unstripped human serum. Among them, the detected contents of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D2 in the blank serum matrix were 0, and the detected contents of vitamin A1, vitamin E and vitamin K1 were less than 1% of the detected contents in the unstripped human serum. The stripping solvent can effectively strip the fat-soluble vitamins in human serum.
[0095] <Example 2>
[0096] Ceramide blank plasma preparation
[0097] The biological fluid is human plasma. Human plasma from multiple sources is mixed together, for example, plasma from 30 people is mixed together, i.e., mixed plasma. A portion of the mixed plasma is used to prepare a blank plasma matrix, and a portion is used for comparison. In the stripping solvent, the mass percentages of isopropanol, ethanol, and methyl tert-butyl ether are 20%, 10%, and 70%, respectively. The stripping solvent is mixed evenly by vortex mixing. The stripping solvent is added to the mixed plasma in a volume ratio of 1:2 of the mixed plasma: the stripping solvent, and the mixture is mixed head to head for 40 minutes. The mixed solution is centrifuged at a speed of 4000 rpm for 15 minutes to obtain a stratified liquid. The first organic phase layer is on the upper layer. The first main phase layer is on the lower layer. The first organic phase layer is removed. The first main phase layer is mixed with methyl tert-butyl ether in a volume ratio of 1:2 of the mixed first main phase layer: methyl tert-butyl ether, and the mixture is mixed head to head for 10 minutes. Next, the mixture is centrifuged at a speed of 4000 rpm for 10 minutes to obtain a stratified liquid. The second organic phase layer is on the upper layer. The second main phase layer is on the lower layer. The second organic phase layer is removed to obtain a blank plasma matrix. Finally, the blank plasma matrix is freeze-dried to obtain a dry powder of the blank plasma matrix.
[0098] test:
[0099] The dry powder of the blank plasma matrix is reconstituted with ultrapure water to obtain a blank plasma matrix in a solution state. The ratio of ultrapure water to dry powder in this embodiment is 10.0295, that is, when the mass of the dry powder of the blank plasma matrix is 1 g, 10.0295 g of ultrapure water is added for reconstitution.
[0100] The results were analyzed by liquid chromatography-tandem mass spectrometry (SCIEX Triple Quad TM 4500 MD LC-MS / MS system) was used to detect the contents of seven ceramides in the blank plasma matrix and the unstripped mixed plasma. The measurement results are shown in Figure 1 and Figure 2 .
[0101] Figure 1The peaks are the 7 ceramides and the corresponding internal standards in the unstripped mixed plasma, where the 7 ceramides include: 1, Cer (d18:1 / 14:0); 3, Cer (d18:1 / 16:0); 5, Cer (d18:1 / 18:0); 7, Cer (d18:1 / 20:0); 9, Cer (d18:1 / 22:0); 11, Cer (d18:1 / 24:0); 13, Cer (d18:1 / 24:1). The 7 internal standards corresponding to the 7 ceramides include: 2, Cer (d18:1-d7 / 14:0); 4, Cer (d18:1-d7 / 16:0); 6, Cer (d18:1-d7 / 18:0); 8, Cer (d18:1-d7 / 20:0); 10, Cer (d18:1-d7 / 22:0); 12, Cer (d18:1-d7 / 24:0); 14, Cer (d18:1-d7 / 24:1).
[0102] Depend on Figure 2 It can be seen that the peak heights of the seven ceramides in the blank plasma matrix are close to the baseline level. Only the peaks of the seven internal standards can be detected.
[0103] It can be seen that the stripping solvent can effectively strip the seven ceramides in the mixed plasma. Figure 1 It can be seen that the retention times of the internal standards of the seven ceramides in the unstripped mixed plasma chromatogram are the same as those of the internal standards of the seven ceramides in the blank plasma matrix.
[0104] Table 2 - Comparison of the contents and removal rates of seven ceramides in blank plasma matrix and unstripped mixed plasma in Example 2
[0105]
[0106] Note: If the target substance peak signal-to-noise ratio in the test results is less than 3, the content is marked as 0.
[0107] As shown in Table 2, the detected contents of the 7 ceramides in the blank plasma matrix were all 0. The stripping solvent can effectively strip the above 7 ceramides in the mixed plasma.
[0108] <Example 3>
[0109] Preparation of steroid hormone blank serum matrix
[0110] The biological fluid is human serum. Human sera from multiple sources are mixed together, for example, sera from 30 people are mixed together. Part of the mixed human serum is used to prepare a blank biological fluid matrix, and part is used for comparison.
[0111] In the stripping solvent, the mass percentages of isopropanol, glycerol and methyl tert-butyl ether are 15%, 5% and 80% respectively, and all three reagents are chromatographically pure reagents. The stripping solvent is mixed evenly by vortex mixing. The stripping solvent is added to human serum in a ratio of 1:1 by volume of human serum to stripping solvent, mixed for 60 minutes at a speed of 1200 rpm, and then the mixed solution is centrifuged for 10 minutes at a speed of 4000 rpm to obtain a layered liquid. The first organic phase layer is on the upper layer. The first main phase layer is on the lower layer. The first organic phase layer is removed. The first main phase layer is mixed with methyl tert-butyl ether in a ratio of 1:1 by volume of the first main phase layer: methyl tert-butyl ether, and mixed for 20 minutes at a speed of 1200 rpm. Then centrifuged at a speed of 4000 rpm for 10 minutes to obtain a layered liquid. The second organic phase layer is on the upper layer. The second main phase layer is on the lower layer. The second organic phase layer is removed to obtain an empty serum matrix. Finally, the blank serum matrix is freeze-dried to obtain a dry powder of the blank serum matrix.
[0112] The dry powder of the blank serum matrix is reconstituted with ultrapure water to obtain a blank serum matrix in a solution state. In this embodiment, the ratio of ultrapure water to dry powder is 10.8203, that is, when the mass of the dry powder of the blank serum matrix is 1g, 10.8203g of ultrapure water is added for reconstitution.
[0113] The results were analyzed by liquid chromatography-tandem mass spectrometry (SCIEX Triple Quad TM The steroid hormone content in the blank serum matrix and unstripped human serum of this example was detected by using a 6500 LC-MS / MS system, and the removal rate was calculated. The detection results are shown in Table 3.
[0114] Table 3 - Comparison of steroid hormone content in blank serum matrix and unstripped human serum in Example 3
[0115] Note: If the target substance peak signal-to-noise ratio in the test results is less than 3, the content is marked as 0.
[0116] As shown in Table 3, the contents of 13 steroid hormones in the blank serum matrix were all reduced by more than 95% compared with those in the unstripped human serum. TM The detection was performed on a 6500 mass spectrometer. The detected contents of testosterone, 11-deoxycorticosterone, 17-hydroxyprogesterone, corticosterone, aldosterone, estrone, estriol, 17-hydroxypregnenolone, and estrone sulfate in the blank serum matrix were 0. The detected contents of androstenedione, progesterone, cortisone, and cortisol were less than 5% of the detected contents in unstripped human serum. The stripping solvent can effectively strip steroid hormones in human serum.
[0117] <Example 4>
[0118] The biological fluid is mixed serum. The mixed serum is the same as that in Example 1, and the stripping solvent composition and mixing process are the same as those in Example 1. The mixed serum stripping process is the same as that in Example 1. The difference from Example 1 is that after one stripping process is completed, the stripping process is repeated again using the same stripping solvent. The subsequent freeze-drying process, re-dissolution process, sample pre-treatment process and detection process are the same as those in Example 1.
[0119] The content and removal rate of fat-soluble vitamins in the blank serum matrix after stripping and the unstripped human serum of this example are shown in Table 4.
[0120] Table 4 - Comparison of fat-soluble vitamin content in blank serum matrix after stripping and unstripped human serum in Example 4
[0121]
[0122] Note: When the target substance peak signal-to-noise ratio in the test results is <3, the content is marked as 0.
[0123] As shown in Table 4, the contents of the five fat-soluble vitamins in the blank serum matrix were lower, and the detected contents were zero or close to zero. Among them, the removal rates of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, vitamin E and vitamin K1 all reached 100%. The removal rate of vitamin A1 was close to 100%.
[0124] <Example 5>
[0125] The biological fluid is mixed serum. The mixed serum is the same as that in Example 3, the composition of the stripping solvent is isopropanol: methyl tert-butyl ether = 20:80, and the stripping solvent mixing process is the same as that in Example 3. The stripping treatment process of the mixed serum is the same as that in Example 3. The freeze-drying process, the reconstitution process, the sample pre-treatment process and the detection process are the same as those in Example 3.
[0126] The steroid hormone content and removal rate in the blank serum matrix after stripping and the unstripped human serum of this example are shown in Table 5.
[0127] Table 5 - Comparison of steroid hormone content in blank serum matrix after stripping and unstripped human serum in Example 5
[0128]
[0129] Note: When the target substance peak signal-to-noise ratio in the test results is <3, the content is marked as 0.
[0130] As shown in Table 5, the contents of 13 steroid hormones in the blank serum matrix were all reduced by more than 85% compared with those in the unstripped human serum. TM The detection was performed on a 6500 mass spectrometer, and the detected contents of 11-deoxycorticosterone, corticosterone, estrone, and 17-hydroxypregnenolone in the blank serum matrix were 0. The detected contents of androstenedione, testosterone, progesterone, 17-hydroxyprogesterone, cortisone, cortisol, estriol, and estrone sulfate in the blank serum matrix were less than 10% of the detected contents in the unstripped human serum. The stripping solvent can effectively strip the steroid hormones in the mixed serum.
[0131] <Example 6>
[0132] The biological fluid is mixed serum. The mixed serum is the same as that in Example 1, and the stripping solvent, stripping process, freeze-drying process, sample pretreatment process and re-dissolution process during detection are the same as those in Example 1. The unstripped human serum of this example and the blank serum matrix of this example are transferred. Three portions of unstripped human serum and blank serum matrix are transferred, each portion is 400 μL, and added to 6 centrifuge tubes with a capacity of 2.0 mL. Then, 1000 μL of acetonitrile is added to each centrifuge tube and vortexed for 5 minutes. Next, centrifuge at a temperature of 4 ° C and a speed of 15000 rpm / min for 15 minutes to separate the solution. Next, remove the supernatant to obtain a protein precipitate. The mass of the protein precipitate is weighed after freeze-drying. The mass of the protein precipitate in the six centrifuge tubes is shown in Table 6.
[0133] Table 6 - Comparison of protein content of unstripped human serum and blank serum matrix of this example
[0134]
[0135] As shown in Table 6, the difference between the mass of protein precipitate from blank serum matrix and the mass of protein precipitate from unstripped mixed serum is only 0.05%, which indicates that the stripping solvent does not substantially change the protein content of the blank serum matrix.
[0136] <Example 7>
[0137] The biological fluid is human urine. Human urine from multiple sources is mixed together, for example, urine from 30 people is mixed together. Part of the mixed human urine is used to prepare a blank biological fluid matrix, and part is used for comparison.
[0138] The human urine stripping process and freeze-drying process are the same as those in Example 3. The dry powder of the blank urine matrix is reconstituted with ultrapure water to obtain a blank urine matrix in a solution state. In this example, the ratio of ultrapure water to dry powder is 22.57, that is, when the mass of the blank urine matrix dry powder is 1 g, 22.57 g of ultrapure water is added and vortexed to mix.
[0139] The results were analyzed by liquid chromatography-tandem mass spectrometry (SCIEX Triple Quad TM The free cortisol and cortisone in the blank urine matrix of this example and the unstripped urine of this example were detected by using a 4500 MD LC-MS / MS system, and the removal rates were calculated. The detection results are shown in Table 7.
[0140] Table 7 - Comparison of free cortisol and cortisone content in blank urine matrix and unstripped urine of Example 7
[0141]
[0142] Note: If the target substance peak signal-to-noise ratio in the test results is less than 3, the content is marked as 0.
[0143] As shown in Table 7, the free cortisol and cortisone contents in the blank urine matrix were reduced by more than 95% compared with the unstripped urine. Among them, the detected content of free cortisol in the blank urine matrix was 0. The stripping solvent can effectively strip free cortisol and cortisone in human urine.
[0144] <Comparative Example 1>
[0145] The biological fluid is mixed serum. The mixed serum is the same as that in Example 1, and the sum of the mass percentages of isopropanol and ethanol in the stripping solvent and the mass percentage of methyl tert-butyl ether are 40% and 60%, respectively. The stripping solvent mixing process is the same as that in Example 1. The preparation process of the stripping matrix, the freeze-drying process, the fat-soluble vitamin sample pretreatment and the detection process are the same as those in Example 1.
[0146] The content and removal rate of fat-soluble vitamins in the stripped matrix prepared in Comparative Example 1 and in the unstripped human serum are shown in Table 8.
[0147] Table 8 - Comparison of the content of fat-soluble vitamins in the stripped matrix of Comparative Example 1 and the unstripped human serum
[0148]
[0149] Note: If the target substance peak signal-to-noise ratio in the test results is less than 3, the content is marked as 0.
[0150] As can be seen from Table 8, the stripping matrix obtained after stripping human serum with the stripping solvent of Comparative Example 1 has a detection content of zero 25-hydroxyvitamin D2, and the removal rates of the other four are all below 95%, among which the removal rate of vitamin E is close to 85%. The residual vitamin A1, 25-hydroxyvitamin D3, vitamin E and vitamin K1 of the stripping matrix are high. Using the stripping matrix prepared in Comparative Example 1 as a diluent may result in a lower accuracy of the detection result of the target substance.
[0151] <Comparative Example 2>
[0152] The biological fluid is mixed serum. The mixed serum is the same as that in Example 1, and the sum of the mass percentages of isopropanol and ethanol in the stripping solvent and the mass percentage of methyl tert-butyl ether are 60% and 40%, respectively. The stripping solvent mixing process is the same as that in Example 1. After adding the stripping solvent and mixing, protein precipitation is found in the mixed serum.
[0153] This indicates that the protein concentration of the stripped matrix obtained by stripping with the stripping solvent of Comparative Example 2 is significantly different from that of the unstripped mixed serum, and does not meet the requirement that the blank matrix and the unstripped human serum have similar compositions.
[0154] <Comparative Example 3>
[0155] The biological fluid is mixed serum. The mixed serum is the same as that in Example 1, and the stripping solvent is 100% methyl tert-butyl ether. The stripping matrix preparation process, freeze-drying process, sample pretreatment and detection process are the same as those in Example 1.
[0156] The contents and removal rates of the five fat-soluble vitamins in the stripped matrix and unstripped human serum prepared in Comparative Example 3 are shown in Table 9.
[0157] Table 9 - Comparison of the contents of five fat-soluble vitamins in the stripped matrix of Comparative Example 3 and the unstripped human serum
[0158]
[0159] Note: If the target substance peak signal-to-noise ratio in the test results is less than 3, the content is marked as 0.
[0160] As can be seen from Table 9, in the stripping matrix after stripping treatment with the stripping solvent of Comparative Example 3, the removal rates of vitamin A1, 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, and vitamin K1 are about 50%, and the removal rate of vitamin E is less than 40%. Therefore, the residual contents of vitamin A1, 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, vitamin K1, and vitamin E in the stripping matrix after stripping treatment are all high. Using the stripping matrix prepared in Comparative Example 3 as a diluent may result in a lower accuracy of the detection result of the target substance.
[0161] <Comparative Example 4>
[0162] The biological fluid is mixed plasma. The mixed plasma is the same as that in Example 2. Activated carbon is used to strip ceramide from the mixed plasma.
[0163] Step 1: Weigh activated carbon and mixed plasma in the same container at a ratio of 1 mL mixed plasma plus 30 mg activated carbon, mix well, sonicate for 40 min, and then centrifuge at 10,000 rpm for 15 min to collect the supernatant;
[0164] Step 2: Repeat step 1 twice;
[0165] Step 3: Centrifuge the supernatant after three strippings at 10,000 rpm for 15 min, and then take the supernatant;
[0166] Step 4, repeating step 3 6 times to obtain a stripped matrix;
[0167] Step 5: dilute the sample according to the ratio of stripping matrix to ultrapure water = 1:1 (v / v). Then, perform sample pretreatment and sample detection in the same manner as in Example 2.
[0168] The contents and removal rates of seven ceramides in the stripped matrix prepared in Comparative Example 4 and in unstripped human plasma are shown in Table 10.
[0169] Table 10 - Comparison of the contents of seven ceramides in the stripped matrix of Comparative Example 4 and in the unstripped human plasma
[0170]
[0171] As can be seen from Table 10, activated carbon as a stripping agent has a good stripping effect on some ceramides in mixed plasma, such as Cer (d18:1 / 24:0), but has a poor stripping effect on some ceramides, such as Cer (d18:1 / 14:0), Cer (d18:1 / 16:0), and Cer (d18:1 / 18:0). Therefore, the residual contents of Cer (d18:1 / 14:0), Cer (d18:1 / 16:0), and Cer (d18:1 / 18:0) in the stripping matrix after stripping treatment are all high. Using the stripping matrix prepared in Comparative Example 4 as a calibrant and quality control diluent may result in a lower accuracy of the detection results of the target substance.
[0172] Although some specific embodiments of the present invention have been described in detail by way of example, it will be appreciated by those skilled in the art that the above examples are for illustration only and are not intended to limit the scope of the present invention. It will be appreciated by those skilled in the art that the above embodiments may be modified without departing from the scope and spirit of the present invention. The scope of the present invention is defined by the appended claims.
Claims
1. A method for preparing a blank biological liquid matrix, characterized in that: include: Mixing the biological liquid with a stripping solvent for removing fat-soluble vitamins, ceramides, and steroid hormones in the biological liquid, layering to obtain a first organic phase layer and a first main phase layer, removing the first organic phase layer to obtain the first main phase layer, wherein the first main phase layer is a blank biological liquid matrix; The stripping solvent includes alcohol and ether, wherein The alcohol includes isopropanol and ethanol, the ether includes methyl tert-butyl ether, and the ratio of the content of the isopropanol, the content of the ethanol and the content of the methyl tert-butyl ether is (5-15): (1-10): (75-94); or The alcohol includes isopropanol and glycerol, the ether includes methyl tert-butyl ether, and the ratio of the content of the isopropanol, the content of the glycerol and the content of the methyl tert-butyl ether is (10-20): (2-8): (88-72).
2. The preparation method according to claim 1, characterized in that: The biological fluid includes at least one of whole blood, plasma, serum, saliva, urine, cerebrospinal fluid, and milk.
3. The preparation method according to claim 1, characterized in that: The volume ratio of the stripping solvent to the biological fluid is greater than or equal to 1:
2.
4. The preparation method according to claim 1, characterized in that: drying the blank biological liquid matrix to prepare a dry powder; or The method also includes purifying the blank biological liquid matrix, including: adding ether to the obtained blank biological liquid matrix, mixing, layering to obtain a second organic phase layer and a second main phase layer, and removing the second organic phase layer.
5. The preparation method according to claim 4, characterized in that: performing rotary evaporation on the second main phase layer to remove the ether in the second main phase layer; or The second main phase layer is dried to prepare a dry powder.
6. The preparation method according to claim 5, characterized in that: The second main phase layer is dried by freeze drying.
